Heterogeneity remained high when stratifying analysis into subgroups of cancer types, and indicated GR expression is harmful in gynaecological cancers (HR = 1.68, 95% CI (1.00, 2.81)) (Figure 3). This evidence concerns the gene NR3C1 and cancer.